early access

Poseida partners with Cellares on cell therapy factory in a box

With a third partner in tow, Cellares has the expertise it needs to close out the early access program for its flexible cell therapy factory in a box.

Fraiser Kansteiner Jul 14, 2021 7:00am

Sanofi is 1-1 in U.K.: dupilumab early access, but a NICE 'no'

Mar 15, 2017 11:58am